Prasugrel versus clopidogrel in patients with stable coronary artery disease, maintained on chronic aspirin therapy undergoing percutaneous coronary intervention.

Trial Profile

Prasugrel versus clopidogrel in patients with stable coronary artery disease, maintained on chronic aspirin therapy undergoing percutaneous coronary intervention.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Sep 2012

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary) ; Aspirin
  • Indications Coronary artery disease; Embolism and thrombosis; Myocardial infarction
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 05 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top